International Journal of Innovative Research in Science, Engineering and Technology

Nanotechnology: The Medicine of the Future

Hazel Scarlett^{* *}Correspondence: Hazel Scarlett, Editorial Office, International Journal of Innovative Research in Science, Engineering and Technology, Brussels, Belgium, Email:

Author info »

Introduction

Nanotechnology is the science and engineering involved in the design, synthesis, characterization, and use of materials and devices with the smallest functional organization in at least one dimension on the nanoscale scale, or one billionth of a meter. Consideration of individual molecules and interacting groups of molecules concerning the bulk macroscopic properties of the material or device becomes important at these scales, as it has control over the fundamental molecular structure, allowing control over the macroscopic chemical and physical properties. Nanotechnology has various uses in medicine, and this article discusses a few of them.

Mechanisms of Nanotechnology in Medicine

These materials and devices can be designed to interact with cells and tissues at the molecular (i.e., subcellular) level for applications in medicine and physiology, with a high degree of functional specificity, allowing for previously unattainable levels of integration between technology and biological systems. It should be noted that nanotechnology is not a single emerging scientific discipline in and of itself, but rather the convergence of various traditional sciences, such as chemistry, physics, materials science, and biology, to bring together the required collective expertise to develop these novel technologies. The potential of nanotechnology is multifarious, including not just enhancements to existing procedures but also totally new tools and capabilities.

The basic characteristics and bioactivity of pharmaceuticals and other materials can be changed by changing them at the nanoscale scale. These technologies provide control over many properties of medications or agents, such as a) changes in solubility and blood pool retention time; b) controlled release for short or extended periods; and c) environmentally induced controlled release or highly precise site-targeted delivery.

Nanomaterial Applications in Medicine

Fluorescent biological labelling, medication and gene delivery, pathogen detection, protein detection, DNA structure probing, tissue engineering, tumour detection, separation and purification of biological molecules and cells, MRI contrast enhancement, and phagokinetic research are among the uses. Nanomedicine research's long-term objective is to describe the quantitative molecular-scale components known as nanomachinery. Precise control and manipulation of nanomachinery in cells can lead to a deeper knowledge of the cellular processes in living cells, as well as the development of new technologies for disease detection and treatment.

The importance of this research is in the creation of a platform technology that will affect nanoscale imaging methodologies aimed to investigate molecular pathways in living cells. Molecular imaging has developed as a potent method for seeing molecular processes associated with an underlying illness, often before its downstream manifestation. The combination of nanotechnology with molecular imaging provides a diverse platform for the unique creation of nanoprobes with enormous potential to improve the sensitivity, specificity, and signalling capacities of numerous biomarkers in human illnesses. Nanoparticle probes can improve signal sensitivity, spatial resolution, and the capacity to communicate information on biological systems at the molecular and cellular levels. Magnetic nanoparticles can be used as contrast enhancement probes in Magnetic Resonance Imaging (MRI). These magnetic nanoparticles can subsequently be used as a foundation for the incorporation of various functional moieties such as fluorescent tags, radionuclides, and other biomolecules for multimodal imaging, gene delivery, and cellular trafficking. A Magnetic Resonance Imaging (MRI) employing hybrid probes of magnetic nanoparticles and adenovirus may identify target cells and visually monitor gene delivery and expression of green fluorescent proteins. Nuclear methods, like Positron-Emission Tomography (PET), may have better detection sensitivities, allowing the use of nanoparticles at lower concentrations than conventional MRI. Furthermore, hybrid imaging offers the ability to map signals to atherosclerotic vascular regions by combining the high sensitivity of PET with the anatomical information afforded by Computed Tomography (CT). The buildup of the contrast agent in the target location is always required for molecular imaging, and this can be accomplished more effectively by directing nanoparticles bearing the contrast agent into the target. This necessitates the usage of targeting groups to get access to target molecules hiding behind tissue barriers. Nanoparticles with several contrast groups enable signal amplification for imaging modalities with limited sensitivity. In theory, the same nanoparticles can carry both the contrast medium and the medicine, allowing simultaneous monitoring of bio-distribution and therapeutic efficacy (referred to as theranostics). These nanofiber-based scaffolds are available in a variety of pore size distributions, porosities, and surfacearea-to-volume ratios. Such a diverse set of parameters is beneficial for cell attachment, development, and proliferation, and it also serves as a foundation for future improvement of an electrospun nanofibrous scaffold in a tissue-engineering application.

Pharmacokinetic benefits from solid drug nanoparticles

Professor Andrew Owen offered an overview of the uses of Solid Drug nanoparticles (SDN) formulations (University of Liverpool). The presentation focused on 'nanoparticle engineering' to create dispersions in which each submicron particle contains the medicine. Nanomilling is the most commercially successful nanoparticle-engineering technology, relying on the formation of SDNs for applications such as improving oral bioavailability (e.g., dalfampridine), overcoming food effects (e.g., megestrol acetate), modified delivery profile (e.g., Ritalin), and sustainedrelease intramuscular depot formulations (e.g., paliperidone). A new economical, scalable, and adaptable technique for producing antiretroviral SDNs was also demonstrated. The method has resulted in efavirenz oral formulations with preclinical results showing that a dosage decrease may be achieved while preserving plasma exposure.

Conclusion

As a result, it is stated that nanotechnology, or the creation of systems/ devices at the molecular level, is a multidisciplinary scientific discipline undergoing rapid development. Nanotechnology arose from the promise of revolutionary advancements in health, communications, genetics, and robotics.